AIG
TVTX icon

American International Group’s Travere Therapeutics TVTX Stock Holding History

American International Group’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,901
Closed -$277K – 2540
2024
Q1 		$277K Sell
35,901
-308
-0.9% -$2.6K ﹤0.01% 1960
2023
Q4 		$326K Sell
36,209
-147
-0.4% -$1.07K ﹤0.01% 1894
2023
Q3 		$325K Buy
36,356
+1,293
+4% +$18.2K ﹤0.01% 1846
2023
Q2 		$539K Buy
35,063
+5,365
+18% +$97.6K ﹤0.01% 1596
2023
Q1 		$668K Buy
29,698
+591
+2% +$12.6K ﹤0.01% 1444
2022
Q4 		$612K Buy
29,107
+194
+0.7% +$4.11K ﹤0.01% 1480
2022
Q3 		$712K Buy
28,913
+408
+1% +$10.5K 0.01% 1372
2022
Q2 		$691K Sell
28,505
-806
-3% -$20.3K ﹤0.01% 1411
2022
Q1 		$755K Sell
29,311
-2,064
-7% -$54.8K ﹤0.01% 1493
2021
Q4 		$974K Sell
31,375
-532
-2% -$15K ﹤0.01% 1441
2021
Q3 		$774K Sell
31,907
-758
-2% -$13.9K ﹤0.01% 1580
2021
Q2 		$477 Buy
32,665
+417
+1% +$8.22K ﹤0.01% 1958
2021
Q1 		$805 Buy
32,248
+3,809
+13% +$105K ﹤0.01% 1584
2020
Q4 		$775 Sell
28,439
-816
-3% -$19.1K ﹤0.01% 1532
2020
Q3 		$540K Buy
29,255
+3,894
+15% +$75.7K ﹤0.01% 1558
2020
Q2 		$518K Buy
25,361
+848
+3% +$13.5K ﹤0.01% 1573
2020
Q1 		$358K Sell
24,513
-1,416
-5% -$21.3K ﹤0.01% 1588
2019
Q4 		$368K Sell
25,929
-218
-0.8% -$2.79K ﹤0.01% 1864
2019
Q3 		$303K Sell
26,147
-182
-0.7% -$3.01K ﹤0.01% 1939
2019
Q2 		$529K Buy
26,329
+4
+0% +$79 ﹤0.01% 1673
2019
Q1 		$596K Sell
26,325
-852
-3% -$18.8K ﹤0.01% 1608
2018
Q4 		$615K Buy
27,177
+337
+1% +$8.38K ﹤0.01% 1554
2018
Q3 		$771K Buy
26,840
+797
+3% +$22.8K ﹤0.01% 1612
2018
Q2 		$710K Buy
26,043
+878
+3% +$23.4K ﹤0.01% 1601
2018
Q1 		$563K Sell
25,165
-590
-2% -$14.1K ﹤0.01% 1640
2017
Q4 		$543K Buy
25,755
+122
+0.5% +$2.79K ﹤0.01% 1741
2017
Q3 		$638K Buy
25,633
+1,916
+8% +$42.2K ﹤0.01% 1610
2017
Q2 		$460K Buy
23,717
+1,417
+6% +$25.7K ﹤0.01% 1762
2017
Q1 		$412K Buy
22,300
+1,475
+7% +$28.9K ﹤0.01% 1720
2016
Q4 		$394K Sell
20,825
-54
-0.3% -$1.1K ﹤0.01% 1788
2016
Q3 		$467K Buy
20,879
+32
+0.2% +$609 ﹤0.01% 1654
2016
Q2 		$371K Buy
20,847
+351
+2% +$5.68K ﹤0.01% 1755
2016
Q1 		$280K Hold
20,496
– – ﹤0.01% 2478
2015
Q4 		$395K Sell
20,496
-36
-0.2% -$719 ﹤0.01% 2227
2015
Q3 		$416K Buy
20,532
+44
+0.2% +$1.3K ﹤0.01% 2172
2015
Q2 		$679K Buy
20,488
+7,113
+53% +$195K ﹤0.01% 1904
2015
Q1 		$320K Hold
13,375
– – ﹤0.01% 2544
2014
Q4 		$164K Sell
13,375
-529
-4% -$5.47K ﹤0.01% 3129
2014
Q3 		$125K Sell
13,904
-11
-0.1% -$129 ﹤0.01% 3371
2014
Q2 		$163K Buy
+13,915
New +$189K ﹤0.01% 3166

Other funds holding TVTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

American International Group's TVTX Position: Q2 2024 in Review

American International Group sold out of Travere Therapeutics (TVTX) in Q2 2024, closing a stake of 35,901 shares — an estimated $277K sold.

American International Group first reported a position in TVTX in Q2 2014 and held it in 40 quarters. The position peaked at $974K in Q4 2021. 173 funds tracked by Wall St. Rank hold TVTX as of Q2 2024.

  • American International Group reported no remaining Travere Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 35,901 Travere Therapeutics shares in Q2 2024, an estimated $277K.
  • American International Group first reported a position in Travere Therapeutics in Q2 2014 and held it in 40 quarters.
  • American International Group's Travere Therapeutics position peaked at $974K in Q4 2021.
  • 173 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.